Nature’s Sunshine Products (NASDAQ:NATR – Get Free Report) released its earnings results on Tuesday. The company reported $0.30 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.11, FiscalAI reports. Nature’s Sunshine Products had a return on equity of 10.86% and a net margin of 3.18%.The company had revenue of $123.81 million for the quarter, compared to the consensus estimate of $121.62 million.
Nature’s Sunshine Products Price Performance
Shares of NATR stock traded down $0.05 during mid-day trading on Tuesday, hitting $25.08. The company had a trading volume of 134,978 shares, compared to its average volume of 125,213. The stock’s 50 day moving average price is $24.83 and its 200-day moving average price is $20.28. Nature’s Sunshine Products has a 52-week low of $11.01 and a 52-week high of $28.14. The company has a market capitalization of $438.90 million, a P/E ratio of 30.96 and a beta of 0.93.
Insiders Place Their Bets
In other Nature’s Sunshine Products news, EVP Bryant J. Yates sold 1,700 shares of the business’s stock in a transaction on Friday, December 12th. The shares were sold at an average price of $22.29, for a total value of $37,893.00. Following the sale, the executive vice president owned 98,604 shares in the company, valued at $2,197,883.16. The trade was a 1.69% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 5.60% of the company’s stock.
Institutional Investors Weigh In On Nature’s Sunshine Products
Analyst Upgrades and Downgrades
A number of analysts have commented on NATR shares. Weiss Ratings restated a “hold (c+)” rating on shares of Nature’s Sunshine Products in a research report on Monday, December 29th. DA Davidson lifted their price objective on Nature’s Sunshine Products from $21.00 to $23.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Finally, Canaccord Genuity Group boosted their price objective on Nature’s Sunshine Products from $22.00 to $29.00 and gave the company a “buy” rating in a research note on Tuesday. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, Nature’s Sunshine Products presently has an average rating of “Moderate Buy” and an average target price of $26.00.
Check Out Our Latest Stock Analysis on NATR
About Nature’s Sunshine Products
Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.
The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.
Featured Articles
- Five stocks we like better than Nature’s Sunshine Products
- “I just bought 10,000 shares of a $5 stock…”
- The gold chart Wall Street is terrified of…
- Nvidia CEO Issues Bold Tesla Call
- Gold’s Next Surge is Imminent
- Buy this Gold Stock Before May 15th, 2026
Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.
